References
- TerziEIavaroneMPompiliMContrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodulesJ Hepatol201868348549229133247
- Abou-ElkacemLWilsonKEJohnsonSMUltrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound AgentTheranostics20166111740175227570547
- BzylJPalmowskiMRixAThe high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55)Eur Radiol201323246847522878592
- ZhouYGuHXuYTargeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubblesTheranostics20155439941725699099
- ZhangHInghamESGagnonMKInvitro characterization and invivo ultrasound molecular imaging of nucleolin-targeted microbubblesBiomaterials2017118637327940383
- BachawalSVJensenKCWilsonKETianLLutzAMWillmannJKBreast Cancer Detection by B7-H3-Targeted Ultrasound Molecular ImagingCancer Res201575122501250925899053
- CaiWBYangHLZhangJThe Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor ImagingSci Rep201551372526333917
- LiJTianYShanDNeuropeptide Y Y1 receptor-mediated biodegradable photoluminescent nanobubbles as ultrasound contrast agents for targeted breast cancer imagingBiomaterials201711610611727914983
- YangHCaiWXuLNanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumorBiomaterials20153727928825453958
- FanXWangLGuoYXiongXZhuLFangKInhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destructionInt J Nanomedicine2016113585359627536100
- SegersTde RondLde JongNBordenMVersluisMStability of Monodisperse Phospholipid-Coated Microbubbles Formed by Flow-Focusing at High Production RatesLangmuir201632163937394427006083
- PereraRHWuHPeirisPImproving performance of nanoscale ultrasound contrast agents using N,N-diethylacrylamide stabilizationNanomedicine2017131596727565686
- DuanSGuoLShiDShangMMengDLiJDevelopment of a novel folate-modified nanobubbles with improved targeting ability to tumor cellsUltrason Sonochem20173723524328427629
- GaoYHernandezCYuanHXUltrasound molecular imaging of ovarian cancer with CA-125 targeted nanobubble contrast agentsNanomedicine20171372159216828603079
- FanXGuoYWangLXiongXZhuLFangKDiagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubblesInt J Nanomedicine2016113939395027574424
- ChangSSOverview of prostate-specific membrane antigenRev Urol20046Suppl 10S13S18
- TangLTongRCoyleVJTargeting tumor vasculature with aptamer-functionalized doxorubicin-polylactide nanoconjugates for enhanced cancer therapyACS Nano2015955072508125938427
- GarousiJHonarvarHAnderssonKGComparative Evaluation of Affibody Molecules for Radionuclide Imaging of in Vivo Expression of Carbonic Anhydrase IXMol Pharm201613113676368727529191
- EllingsenCAndersenLMGalappathiKRofstadEKHypoxia bio-markers in squamous cell carcinoma of the uterine cervixBMC Cancer20151580526502718
- CovielloVMarchiBSartiniS1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic ConditionsJ Med Chem201659136547655227305384
- Viola-VillegasNTCarlinSDAckerstaffEUnderstanding the pharmacological properties of a metabolic PET tracer in prostate cancerProc Natl Acad Sci U S A2014111207254725924785505
- van BrusselASAdamsAOliveiraSHypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast CancerMol Imaging Biol201618453554426589824
- ZegersCMHoebersFJvan ElmptWEvaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancerEur J Nucl Med Mol Imaging201643122139214627251643
- MuselaersCHRijpkemaMBosDLRadionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250J Urol2015194253253825686542
- ZhuLGuoYWangLConstruction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organsJ Nanobiotechnology20171516328962657
- WuQWuLWangYEvolution of DNA aptamers for malignant brain tumor gliosarcoma cell recognition and clinical tissue imagingBiosens Bioelectron2016801826802746
- KangSATsolmonBMannAPSafety evaluation of intravenously administered mono-thioated aptamer against E-selectin in miceToxicol Appl Pharmacol20152871869226048585
- SongYZhuZAnYSelection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell captureAnal Chem20138584141414923480100
- AlibolandiMRamezaniMAbnousKIn vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancerJ Control Release20152098810025912964
- JacobsonOWeissIDWangL18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 ExpressionJ Nucl Med201556111780178526315836
- GaoZHouYZengJTumor Microenvironment-Triggered Aggregation of Antiphagocytosis 99m Tc-Labeled Fe3 O4 Nanoprobes for Enhanced Tumor Imaging In VivoAdv Mater201729241701095
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- ChenWZhengRZhangSCancer incidence and mortality in China, 2013Cancer Lett2017401637128476483
- DoroudiMSchoenREPinskyPFEarly detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?Cancer2017123244815482228976536
- LiuJChenYWangGUltrasound molecular imaging of acute cardiac transplantation rejection using nanobubbles targeted to T lymphocytesBiomaterials201816220020729453053
- ZhouTCaiWYangHAnnexin V conjugated nanobubbles: A novel ultrasound contrast agent for in vivo assessment of the apoptotic response in cancer therapyJ Control Release201827611312429522835
- WangSHerbstEBMauldinFWDiakovaGBKlibanovALHossackJAUltra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?Invest Radiol2016511275876627654582
- SunYMaXChengKStrained cyclooctyne as a molecular platform for construction of multimodal imaging probesAngew Chem Int Ed Engl201554205981598425800807
- DingFChenSZhangWTuYSunYUPAR targeted molecular imaging of cancers with small molecule-based probesBioorg Med Chem201725205179518428869084
- DingFZhanYLuXSunYRecent advances in near-infrared II fluorophores for multifunctional biomedical imagingChem Sci20189194370438029896378
- SunYZengXXiaoYNovel dual-function near-infrared II fluorescence and PET probe for tumor delineation and image-guided surgeryChem Sci2018982092209729675250
- LutzAMBachawalSVDrescherCWPyszMAWillmannJKGambhirSSUltrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer modelClin Cancer Res20142051313132224389327
- HoytKWarramJMWangDRatnayakaSTraylorAAgarwalAMolecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney InjuryMol Imaging Biol201517678679225905474
- Baron ToaldoMSalvatoreVMarinelliSUse of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinomaMol Imaging Biol2015171293725082536
- HacklCSchachererDAndersMImproved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55Ultraschall Med201637329029627112624
- WillmannJKBonomoLCarla TestaAUltrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human ResultsJ Clin Oncol201735192133214028291391
- SmeengeMTranquartFMannaertsCKFirst-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot StudyInvest Radiol201752741942728257340
- OdaYSuzukiRMoriTDevelopment of fluorous lipid-based nanobubbles for efficiently containing perfluoropropaneInt J Pharm20154871–2647125841568
- HoYJChangYCYehCKImproving Nanoparticle Penetration in Tumors by Vascular Disruption with Acoustic Droplet VaporizationTheranostics20166339240326909113
- WuMWangYWangYPaclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancerInt J Nanomedicine2017125313533028794625
- WuMZhaoHGuoLUltrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancerDrug Deliv201825122624029313393
- ZhangHTamSInghamESUltrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubbleBiomaterials20155610411325934284
- HouYQiaoRFangFNaGdF4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts in vivoACS Nano20137133033823199030